Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2012: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Outline of Final Research Achievements |
The leading cause of blindness in Japan is glaucoma, which is one of neurodegenerative disorders. We have previously demonstrated that apolipoprotein E-containing lipoproteins strongly protect primary cultured retinal ganglion cells from trophic factors-withdrawal-induced neurodegeneration. In this study, we showed a neuroprotective mechanism of apolipoprotein E-containing lipoproteins via the lipoprotein receptor against glutamate-induced neurotoxicity. We believe that the results of this study provide a novel therapeutic approach for glaucoma.
|